A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.George A. Fisher, Amita Patnaik, Johanna C. Bendell et al.|Journal of Clinical Oncology|2020Cited by 53
A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.Nehal J. Lakhani, Kathleen N. Moore, Amita Patnaik et al.|Journal of Clinical Oncology|2020Cited by 37